Savara Fully Acquires Serendex, Readies Phase 3 Trial of Inhaled Antibiotic for CF Lung Infections click here By John Harbison|2017-02-19T09:15:00-08:00July 20, 2016|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Savara Fully Acquires Serendex, Readies Phase 3 Trial of Inhaled Antibiotic for CF Lung Infections Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
